| 000 | 01674 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514230901.0 | ||
| 264 | 0 | _c20051024 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a1121-8428 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTong, Matthew Ka Hang | |
| 245 | 0 | 0 |
_aUse of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis. _h[electronic resource] |
| 260 |
_bJournal of nephrology _c |
||
| 300 |
_a204-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xcomplications |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPeritoneal Dialysis, Continuous Ambulatory |
| 650 | 0 | 4 |
_aPeritonitis _xcomplications |
| 650 | 0 | 4 |
_aPlasminogen Activators _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRenal Insufficiency _xcomplications |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xadministration & dosage |
| 700 | 1 | _aLeung, Kay Tai | |
| 700 | 1 | _aSiu, Yui-Pong | |
| 700 | 1 | _aLee, Kit Fan | |
| 700 | 1 | _aLee, Hoi Kan | |
| 700 | 1 | _aYung, Chun Yun | |
| 700 | 1 | _aKwan, Tze Hoi | |
| 700 | 1 | _aAu, Tak Cheung | |
| 773 | 0 |
_tJournal of nephrology _gvol. 18 _gno. 2 _gp. 204-8 |
|
| 999 |
_c15592305 _d15592305 |
||